Comparison of the effect of using electromagnetic waves with gabapentin in the treatment of tinnitus

Evaluation of the efficacy of tinnitus treatment using rTMS compared to gabapentin

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130311012782N62

Enrollment

Registered

2024-12-11

Start date

2024-12-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tinnitus. Tinnitus

Interventions

Intervention 1: Intervention group1: Patients undergo rTMS treatment for 10 sessions every other day (for 20 days). Intervention 2: Intervention group 2: Patients receive 500 mg of gabapentin manufact

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Known tinnitus Known sensitivity to Gabapentin No use of psychoactive drugs and narcotics No hearing loss or deafness Not using hearing aids Not taking ototoxic drugs Patient's consent to continue participating in the study

Exclusion criteria

Exclusion criteria: Lack of follow-up visits of the patient Use of parallel treatments

Design outcomes

Primary

Measure	Time frame
Tinnitus Intensity. Timepoint: Before treatment and at 3, 6 and 12 weeks after starting treatment. Method of measurement: THI questionnaire(Tinnitus Handicap Inventory).;Tinnitus improvement. Timepoint: 1, 3, 6 and 12 weeks after starting treatment. Method of measurement: Patient recovery as complete recovery, partial recovery, no recovery, and worsened according to the patient's opinion.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamidreza Abtahi

Esfahan University of Medical Sciences

hsrabtahi@gmail.com+98 31 3669 2174

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026